Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Non-Human Primates |
Host species | Mouse |
Applications | IF,Flow Cyt |
Brand: | Abnova |
Reference: | MAB4528 |
Product name: | TP53 monoclonal antibody, clone BP53-12 (FITC) |
Product description: | Mouse monoclonal antibody raised against recombinant TP53. |
Clone: | BP53-12 |
Isotype: | IgG2a |
Gene id: | 7157 |
Gene name: | TP53 |
Gene alias: | FLJ92943|LFS1|TRP53|p53 |
Gene description: | tumor protein p53 |
Immunogen: | Recombinant protein corresponding to full length human TP53. |
Form: | Liquid |
Concentration: | 1 mg/mL |
Recommend dilutions: | The optimal working dilution should be determined by the end user. |
Storage buffer: | In PBS, pH 7.2 (0.09% sodium azide) |
Storage instruction: | Store in the dark at 4°C. Do not freeze. Avoid prolonged exposure to light. Aliquot to avoid repeated freezing and thawing. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Conjugate tag: | FITC |
Product type: | Primary antibodies |
Host species: | Mouse |
Antigen species / target species: | Human |
Specificity: | This antibody recognizes defined epitope (aa 16-25) on human p53, a 50 KDa tumour suppressor found in increased amounts in a wide variety of transformed cells. |
Reactivity: | Human,Non-Human Primates |
Application image: | ![]() |
Application image note: | Confocal microscopy of human HeLa cells using TP53 monoclonal antibody, clone BP53-12 (FITC) (Cat # MAB4528). The expression of TP53 protein was enhanced by intercalating reagent. Cells were fixed and permeabilized before incubation with the TP53 monoclonal antibody, clone BP53-12 (FITC) (Cat # MAB4528). Photo provided by Dr. Hodny, Inst. of Experimental Medicine, Prague, Czech Republic. |
Applications: | IF,Flow Cyt |
Shipping condition: | Blue Ice |
Publications: | p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.Bartkova J, Bartek J, Lukas J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Midgley CA, Lane DP. Int J Cancer. 1991 Sep 9;49(2):196-202. |